Evommune grants CEO $686,600 cash retention award
EVMN•
EVMN•Evommune awarded CEO Luis Peña a $686,600 cash retention award, alongside awards of $565,000 for CFO Kyle Carver and $595,000 for Chief Business & Legal Officer Gregory Moss. The company also repriced options covering 3,692,840 shares to $7.63 per share from exercise prices of $16 to $26.77.
Evommune granted cash retention awards of $686,600 to CEO Luis Peña, $565,000 to CFO Kyle Carver and $595,000 to Chief Business & Legal Officer Gregory Moss. The awards vest in equal installments on the first two anniversaries of amendments to their employment agreements, subject to continued employment; second installments also depend on the stock closing at $15 on the second anniversary or averaging $15 over 15 trading days during the preceding year. Evommune repriced options covering 3,692,840 shares to $7.63 per share on November 13, 2026, from original exercise prices ranging from $16 to $26.77; accessing the reduced price generally requires 12 months of continuous service.